RFP 2024.12 – Consultancy services to provide an overview of medicines, including pipeline products, for treatment of hepatitis B and/or hepatitis D

WHO
RFP 2024.12 – Consultancy services to provide an overview of medicines, including pipeline products, for treatment of hepatitis B and/or hepatitis D Request for proposal

Reference: RFP 2024.12
Beneficiary countries or territories: Switzerland
Published on: 26-Jul-2024
Deadline on: 09-Sep-2024 17:00 (GMT 1.00)

Description

RFP 2024.12 – Consultancy services to provide an overview of medicines, including pipeline products, for treatment of hepatitis B and/or hepatitis D

 

In order to access the RFP documents, please log-in as a registered Supplier (Account registration accessible on https://www.ungm.org/Account/Registration).

If you experience difficulties in accessing the RFP documents after having registered and expressed interest, please send an email to: unitaid-proc@who.int.

 

Objective of the consultancy:

 

The purpose of this Request for Proposal (RFP) is to identify qualified experts (consultancy firms) to develop technology landscape documents on medicines for hepatitis B and/or hepatitis D with a focus on products that have recently been launched and that are in development.

 

Qualification of Firm and Consultants:

 

The Contractor is expected to propose expert(s) that can support the work described above, with adequate expertise. The firm and the proposed team member(s) shall demonstrate adequate experience as below:

 

Essential experience and educational requirements

1. At least 10 years’ work experience in global public health.

2. Experience in horizon scanning for new technologies in global health.

3. Experience working on viral hepatitis, preferably experience related to enhancing access to treatments for viral hepatitis for low- and middle-income countries.

4. Excellent written communication skills in English, with experience in developing technical reports and the ability to distil complex subjects in clear and accessible messages for a range of audiences (please include samples or links to the similar reports produced).

Desirable experience

1. Experience working on hepatitis B and/or hepatitis D. 

2. Experience with compiling, assessing and comparing clinical trial data.

3. Experience in horizon scanning for new technologies in viral hepatitis.

4. Having a well-established network of relevant contacts in industry, academia, international agencies, etc.

5. Working knowledge of Unitaid and/or the World Health Organization.

6. Product development and commercialization in global health, and particularly related to hepatitis B and/or hepatitis D treatments.

 

Proposals must be submitted to unitaid-proc@who.int no later than 17:00 hours Geneva time, 09 September 2024. Please separate the Technical and Financial proposals in different files.

 

We look forward to receiving your proposals.

 

Unitaid Procurement